4.5 Review

Vascular KCa-channels as therapeutic targets in hypertension and restenosis disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Pharmacology & Pharmacy

Calcium-activated potassium channels and endothelial dysfunction: therapeutic options?

Michel Feletou

BRITISH JOURNAL OF PHARMACOLOGY (2009)

Article Multidisciplinary Sciences

Hypertension of Kcnmb1-/- is linked to deficient K secretion and aldosteronism

P. Richard Grimm et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Multidisciplinary Sciences

Renal fibrosis is attenuated by targeted disruption of KCa3.1 potassium channels

Ivica Grgic et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Physiology

Hypercontractility and impaired sildenafil relaxations in the BKCa channel deletion model of erectile dysfunction

Matthias E. Werner et al.

AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2008)

Review Biochemistry & Molecular Biology

Molecular and cellular basis of small- and intermediate-conductance, calcium-activated potassium channel function in the brain

P. Pedarzani et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2008)

Review Chemistry, Multidisciplinary

K+ channel modulators for the treatment of neurological disorders and autoimmune diseases

Heike Wulff et al.

CHEMICAL REVIEWS (2008)

Review Medicine, Research & Experimental

Preventing restenosis after angioplasty: a multistage approach

Ramin Zargham

CLINICAL SCIENCE (2008)

Review Biochemistry & Molecular Biology

BK channel modulators: A comprehensive overview

Antonio Nardi et al.

CURRENT MEDICINAL CHEMISTRY (2008)

Article Medicine, Research & Experimental

The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans

Kazuyoshi Toyama et al.

JOURNAL OF CLINICAL INVESTIGATION (2008)

Article Chemistry, Medicinal

Novel inhibitors of the Gardos channel for the treatment of sickle cell disease

Grant A. McNaughton-Smith et al.

JOURNAL OF MEDICINAL CHEMISTRY (2008)

Article Pharmacology & Pharmacy

Systemic activation of the transient receptor potential vanilloid subtype 4 channel causes endothelial failure and circulatory collapse: Part 2

Robert N. Willette et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)

Article Pharmacology & Pharmacy

Openers of calcium-activated potassium channels and endothelium-dependent hyperpolarizations in the guinea pig carotid artery

V. Leuranguer et al.

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2008)

Article Multidisciplinary Sciences

Functional architecture of inositol 1,4,5-trisphosphate signaling in restricted spaces of myoendothelial projections

Jonathan Ledoux et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Pharmacology & Pharmacy

The small molecule NS11021 is a potent and specific activator of Ca2+-activated big-conductance K+ channels

Bo Hjorth Bentzen et al.

MOLECULAR PHARMACOLOGY (2007)

Article Pharmacology & Pharmacy

Reduction of NO- and EDHF-mediated vasodilatation in hypertension: Role of asymmetric dimethylarginine

Jie Li et al.

CLINICAL AND EXPERIMENTAL HYPERTENSION (2007)

Article Cardiac & Cardiovascular Systems

Hypersensitivity of BKCa to Ca2+ sparks underlies hyporeactivity of arterial smooth muscle in shock

Guiling Zhao et al.

CIRCULATION RESEARCH (2007)

Review Urology & Nephrology

The endothelium-derived hyperpolarizing factor:: insights from genetic animal models

R. Koehler et al.

KIDNEY INTERNATIONAL (2007)

Article Pharmacology & Pharmacy

Selective positive modulation of the SK3 and SK2 subtypes of small conductance Ca2+-activated K+ channels

C. Hougaard et al.

BRITISH JOURNAL OF PHARMACOLOGY (2007)

Article Peripheral Vascular Disease

Arachidonic acid metabolites as endothelium-derived hyperpolarizing factors

William B. Campbell et al.

HYPERTENSION (2007)

Review Biochemistry & Molecular Biology

Modulators of small- and intermediate-conductance calcium-activated potassium channels and their therapeutic indications

Heike Wulff et al.

CURRENT MEDICINAL CHEMISTRY (2007)

Article Pharmacology & Pharmacy

Mitogenic modulation of Ca2+-activated K+ channels in proliferating A7r5 vascular smooth muscle cells

Han Si et al.

BRITISH JOURNAL OF PHARMACOLOGY (2006)

Article Pharmacology & Pharmacy

Impaired small-conductance Ca2+-activated K+ channel-dependent EDHF responses in type II diabetic ZDF rats

MP Burnham et al.

BRITISH JOURNAL OF PHARMACOLOGY (2006)

Article Biotechnology & Applied Microbiology

hMaxi-K gene transfer in males with erectile dysfunction:: Results of the first human trial

Arnold Melman et al.

HUMAN GENE THERAPY (2006)

Article Pharmacology & Pharmacy

Dose-escalation study of ICA-17043 in patients with sickle cell disease

Kenneth I. Ataga et al.

PHARMACOTHERAPY (2006)

Article Cardiac & Cardiovascular Systems

Endothelial dysfunction:: a multifaceted disorder

Michel Feletou et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)

Review Hematology

Endothelium-derived hyperpolarizing factor - Where are we now?

Michel Feletou et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)

Review Cardiac & Cardiovascular Systems

Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in animals and humans

H Shimokawa et al.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2005)

Article Cardiac & Cardiovascular Systems

Reduced molecular expression of K+ channel proteins in vascular smooth muscle from rats made hypertensive with Nω-nitro-L-arginine

IN Bratz et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)

Article Medicine, Research & Experimental

Gain-of-function mutation in the KCNMB1 potassium channel subunit is associated with low prevalence of diastolic hypertension

JM Fernández-Fernández et al.

JOURNAL OF CLINICAL INVESTIGATION (2004)

Review Pharmacology & Pharmacy

Endothelium-dependent smooth muscle hyperpolarization: do gap junctions provide a unifying hypothesis?

TM Griffith

BRITISH JOURNAL OF PHARMACOLOGY (2004)

Review Urology & Nephrology

Endothelial dysfunction

DH Endemann et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)

Review Pharmacology & Pharmacy

EDHF:: new therapeutic targets?

M Félétou et al.

PHARMACOLOGICAL RESEARCH (2004)

Article Biochemistry & Molecular Biology

Activation of human IK and SK Ca2+-activated K+ channels by NS309 (6,7-dichloro-1H-indole-2,3-dione 3-oxime)

D Strobæk et al.

BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2004)

Article Cardiac & Cardiovascular Systems

Downregulation of the BK channel β1 subunit in genetic hypertension

GC Amberg et al.

CIRCULATION RESEARCH (2003)

Review Pharmacology & Pharmacy

EDHF:: bringing the concepts together

R Busse et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2002)

Article Cardiac & Cardiovascular Systems

Impaired hyperpolarization in regenerated endothelium after balloon catheter injury

R Köhler et al.

CIRCULATION RESEARCH (2001)

Article Neurosciences

Pharmacological modulation of SK3 channels

M Grunnet et al.

NEUROPHARMACOLOGY (2001)

Article Biochemistry & Molecular Biology

Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels

VK Gribkoff et al.

NATURE MEDICINE (2001)

Article Biochemistry & Molecular Biology

Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation

CJ Sinal et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2000)

Article Multidisciplinary Sciences

Vasoregulation by the β1 subunit of the calcium-activated potassium channel

R Brenner et al.

NATURE (2000)